These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians. Mascolini M; Wensing AM; Boucher CA IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306 [No Abstract] [Full Text] [Related]
12. When to start antiretroviral therapy? NA-ACCORD stimulates the debate. Gallant JE AIDS Read; 2009 Feb; 19(2):49-50, 61. PubMed ID: 19271328 [No Abstract] [Full Text] [Related]
13. Arriving too soon: suggestions for the coming generation of "heavily treated" patients. Simmons P Res Initiat Treat Action; 2000 Sep; 6(3):5-6. PubMed ID: 11708166 [No Abstract] [Full Text] [Related]
14. HIV therapeutics: points from the recent literature. Laurence J AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448 [No Abstract] [Full Text] [Related]
15. The next big challenge: managing HIV infection in an age of higher resistance. AIDS Alert; 2001 Dec; 16(12):153, 155-7. PubMed ID: 11768873 [No Abstract] [Full Text] [Related]
16. Editorial comment: strategies for success--a return to "hit early"? Gallant JE AIDS Read; 2004 Dec; 14(12):662-3. PubMed ID: 15619782 [No Abstract] [Full Text] [Related]
17. Anti-HIV agents. New evidence changes guidelines about when to start treatment. TreatmentUpdate; 2009 Jan; 21(1):2-4. PubMed ID: 19248282 [No Abstract] [Full Text] [Related]
19. Antiretroviral rounds. CD4 count 423, viral load 12,000: time to treat anyway? Hodder S; Frank I AIDS Clin Care; 2006 Jun; 18(6):59-60. PubMed ID: 16791955 [No Abstract] [Full Text] [Related]
20. Solid organ transplantation in HIV-infected individuals. Roland M; Carlson L; Stock P AIDS Clin Care; 2002 Jul; 14(7):59-63. PubMed ID: 12090255 [No Abstract] [Full Text] [Related] [Next] [New Search]